D&O initial disclosures – multiple

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
11/02/21
Date on which issuer listed or appointment made:
11/02/21
Director or senior manager giving disclosure
Full name:
Bessie Marsh
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Senior Manager
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares
Number held in class:70250
Nature of relevant interest:
(1) 250 shares held as registered and
beneficial owner; (2) 20000 shares
held by XZS Holdings Limited in its
capacity as trustee of a family trust
associated with Bessie Marsh; (3)
50000 shares (currently held by the
Third Age Health Services Limited
Employee Share Purchase Plan Trust)
that Bessie has an option to purchase
Current registered holder:
(1) Bessie Marsh; (2) XYS Holdings
Limited; (3) Bevan John Walsh and
Michael Bruce Haskell (in their capacity
as trustees of Third Age Health
Services Limited Employee Share
Purchase Plan Trust)
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
Class of underlying financial products:
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying products
(if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
Signature of director or officer:
Date of signature:11/02/21
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:

---

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
11/02/21
Date on which issuer listed or appointment made:
11/02/21
Director or senior manager giving disclosure
Full name:
Campbell Joseph Patterson
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Senior Manager
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares
Number held in class:20250
Nature of relevant interest:
(1) 250 shares held as registered and
beneficial owner; (2) 20000 shares
held by XZS Holdings Limited in its
capacity as trustee of a family trust
associated with Campbell Patterson
Current registered holder:
(1) Campbell Patterson; (2) XYS
Holdings Limited
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
Class of underlying financial products:
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying products
(if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
Signature of director or officer:
Date of signature:11/02/21
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:

---

Initial Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(1) and 298(1), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Third Age Health Services Limited
Date this disclosure made:
11/02/2021
Date on which issuer listed or appointment made:
11/02/2021
Director or senior manager giving disclosure
Full name:
Norah Kathleen Barlow
Name of listed issuer:
Third Age Health Services Limited
Name of related body corporate (if applicable):
Position held in listed issuer:
Director
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary shares
Number held in class:24490
Nature of relevant interest:
Shares held by Norah Kathleen
Barlow and Robert Noel Barlow in
their capacities as trustees of a
family trust associated with Norah
Barlow
Current registered holder:
Norah Kathleen Barlow and Robert
Noel Barlow
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
Class of underlying financial products:
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:11/02/2021
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person: